Brokerages Set Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Target Price at $11.86

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has received an average recommendation of “Hold” from the eleven ratings firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $11.86.

MDRX has been the topic of several research reports. Evercore ISI reiterated a “hold” rating and issued a $11.50 price target on shares of Allscripts Healthcare Solutions in a research report on Sunday, August 11th. Robert W. Baird set a $13.00 target price on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research note on Monday, August 12th. TheStreet upgraded shares of Allscripts Healthcare Solutions from a “d+” rating to a “c-” rating in a report on Friday, September 20th. Deutsche Bank started coverage on shares of Allscripts Healthcare Solutions in a research report on Thursday, September 26th. They set a “hold” rating and a $11.00 price target for the company. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a report on Tuesday, November 5th.

Large investors have recently modified their holdings of the business. First Trust Advisors LP raised its holdings in Allscripts Healthcare Solutions by 110.5% during the first quarter. First Trust Advisors LP now owns 79,028 shares of the software maker’s stock worth $754,000 after purchasing an additional 41,492 shares in the last quarter. Zeke Capital Advisors LLC grew its holdings in Allscripts Healthcare Solutions by 13.8% during the second quarter. Zeke Capital Advisors LLC now owns 86,182 shares of the software maker’s stock worth $1,002,000 after acquiring an additional 10,466 shares during the period. Rothschild & Co. Asset Management US Inc. grew its holdings in Allscripts Healthcare Solutions by 6.1% during the second quarter. Rothschild & Co. Asset Management US Inc. now owns 1,139,996 shares of the software maker’s stock worth $13,258,000 after acquiring an additional 65,924 shares during the period. Creative Planning raised its position in Allscripts Healthcare Solutions by 11.9% in the second quarter. Creative Planning now owns 23,103 shares of the software maker’s stock worth $269,000 after acquiring an additional 2,460 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Allscripts Healthcare Solutions by 16.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,460 shares of the software maker’s stock valued at $145,000 after acquiring an additional 1,800 shares during the last quarter.

MDRX stock traded up $0.04 on Tuesday, reaching $10.06. 2,234,945 shares of the company’s stock were exchanged, compared to its average volume of 1,898,758. The stock has a fifty day moving average of $10.90 and a 200-day moving average of $10.49. The firm has a market cap of $1.63 billion, a PE ratio of 19.65, a P/E/G ratio of 1.93 and a beta of 1.40. The company has a quick ratio of 0.66, a current ratio of 0.66 and a debt-to-equity ratio of 0.51. Allscripts Healthcare Solutions has a twelve month low of $8.54 and a twelve month high of $12.40.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Monday, November 4th. The software maker reported $0.17 EPS for the quarter, meeting analysts’ consensus estimates of $0.17. The company had revenue of $445.00 million during the quarter, compared to the consensus estimate of $450.04 million. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. Allscripts Healthcare Solutions’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.18 earnings per share. On average, equities research analysts predict that Allscripts Healthcare Solutions will post 0.49 EPS for the current fiscal year.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Story: Stochastic Momentum Index (SMI)

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.